Checkpoint inhibitors assessment in oropharynx carcinoma (CIAO).

Authors

Renata Ferrarotto

Renata Ferrarotto

The University of Texas MD Anderson Cancer Center, Houston, TX

Renata Ferrarotto, Bonnie S. Glisson, Diana Bell, Kate A. Hutcheson, Jack Phan, Hai T. Tran, Dyanne L Gibbs, J. Jack Lee, Maura L. Gillison, Andrew G. Sikora, Neil D. Gross

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A

Track

Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Breast and Gynecologic Cancers,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Oncolytic Viruses

Sub Track

Immune Checkpoints and Stimulatory Receptors

Clinical Trial Registration Number

NCT03144778

Citation

J Clin Oncol 36, 2018 (suppl 5S; abstr TPS118)

DOI

10.1200/JCO.2018.36.5_suppl.TPS118

Abstract #

TPS118

Poster Bd #

N3

Abstract Disclosures